05/06/2025 7:00 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/28/2025 3:44 PM | Vera Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/26/2025 3:21 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/26/2025 7:00 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/20/2025 3:05 PM | JOHNSON DAVID LEE (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2025 3:07 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2025 3:08 PM | Grant Sean (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2025 3:10 PM | Brenner Robert (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2025 8:30 AM | Avoro Capital Advisors LLC (Filed by) Vera Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
01/13/2025 7:06 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/08/2025 3:22 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for VERA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vera Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
12/18/2024 3:24 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024 3:59 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2024 3:05 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/25/2024 3:40 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024 11:15 AM | Kynam Capital Management, LP (Filed by) Vera Therapeutics (Subject)
| Form SC 13G/A | |
11/14/2024 8:35 AM | Avoro Capital Advisors LLC (Filed by) Vera Therapeutics (Subject)
| Form SC 13G | |
11/12/2024 9:34 AM | FMR LLC (Filed by) Vera Therapeutics (Subject)
| Form SC 13G/A | |
11/07/2024 7:00 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/04/2024 6:49 PM | Longitude Capital Partners IV, LLC (Filed by) Vera Therapeutics (Subject)
| Form SC 13D/A | |
10/31/2024 5:05 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/30/2024 3:15 PM | Vera Therapeutics (Filer)
| Form 424B5 | |
10/29/2024 5:15 AM | Vera Therapeutics (Filer)
| Form 424B5 | |
10/28/2024 4:29 PM | Vera Therapeutics (Filer)
| Form S-3ASR | |
10/28/2024 4:30 PM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/28/2024 3:37 PM | SEIDENBERG BETH C (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2024 3:16 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/11/2024 3:05 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/09/2024 3:17 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/02/2024 8:01 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/27/2024 3:05 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/20/2024 3:45 PM | SEIDENBERG BETH C (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2024 3:38 PM | SEIDENBERG BETH C (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2024 3:38 PM | SEIDENBERG BETH C (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024 3:36 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2024 3:19 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024 3:04 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2024 4:40 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/16/2024 3:31 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/14/2024 3:24 PM | Fordyce Marshall (Reporting) Vera Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/08/2024 3:36 PM | Vera Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
Trump’s treachery (Ad) Trump’s Final Reset
Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now. Millions of Americans are about to be wiped out, while others could make a fortune… click here to ma |
08/08/2024 7:00 AM | Vera Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |